169 related articles for article (PubMed ID: 10378695)
1. The v-myc oncogene.
Lee CM; Reddy EP
Oncogene; 1999 May; 18(19):2997-3003. PubMed ID: 10378695
[TBL] [Abstract][Full Text] [Related]
2. Transformation of murine myelomonocytic cells by myc: point mutations in v-myc contribute synergistically to transforming potential.
Symonds G; Hartshorn A; Kennewell A; O'Mara MA; Bruskin A; Bishop JM
Oncogene; 1989 Mar; 4(3):285-94. PubMed ID: 2649846
[TBL] [Abstract][Full Text] [Related]
3. Activation of the M-CSF gene in mouse macrophages immortalized by retroviruses carrying a v-myc oncogene.
Righi M; Sassano M; Valsasnini P; Shammah S; Ricciardi-Castagnoli P
Oncogene; 1991 Jan; 6(1):103-11. PubMed ID: 1825138
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis in v-myc transformation of myelomonocytic cells and its modulation by CSF-1.
Dolnikov A; Ward RL; Hawkins NJ; Symonds G
Oncogene; 1996 Mar; 12(6):1189-98. PubMed ID: 8649820
[TBL] [Abstract][Full Text] [Related]
5. MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation.
Schreiner S; Birke M; García-Cuéllar MP; Zilles O; Greil J; Slany RK
Cancer Res; 2001 Sep; 61(17):6480-6. PubMed ID: 11522644
[TBL] [Abstract][Full Text] [Related]
6. Tumor progression following transformation of murine monocytes by v-myc: acquisition of immortalization and tumorigenicity.
Stapleton P; Takayama Y; Hartshorn A; Kalaizis A; Rowe PB; Symonds G
Oncogene; 1991 May; 6(5):807-17. PubMed ID: 1711191
[TBL] [Abstract][Full Text] [Related]
7. Induced p21WAF1 expression acts to reverse myc myelomonocytic cell transformation.
Dolnikov A; Millington M; Sun LQ; Symonds G
Cancer Gene Ther; 2000 Nov; 7(11):1491-503. PubMed ID: 11129291
[TBL] [Abstract][Full Text] [Related]
8. The myc gene family proteins and their role in transformation and differentiation.
Ingvarsson S
Semin Cancer Biol; 1990 Dec; 1(6):359-69. PubMed ID: 2103508
[TBL] [Abstract][Full Text] [Related]
9. v-Myc is invariably required to sustain rapid proliferation of infected cells but in stable cell lines becomes dispensable for other traits of the transformed phenotype.
Tikhonenko AT; Black DJ; Linial ML
Oncogene; 1995 Oct; 11(8):1499-508. PubMed ID: 7478574
[TBL] [Abstract][Full Text] [Related]
10. Examination of the role of CSF-1 independence in myc retrovirus induced monocyte tumorigenesis.
Eccles MR; Baumbach WR; Cole MD
Oncogene; 1990 Oct; 5(10):1535-9. PubMed ID: 2250911
[TBL] [Abstract][Full Text] [Related]
11. Constitutive expression of exogenous myc in myelomonocytic cells: acquisition of a more transformed phenotype and inhibition of differentiation induction.
Chisholm O; Stapleton P; Symonds G
Oncogene; 1992 Sep; 7(9):1827-36. PubMed ID: 1501891
[TBL] [Abstract][Full Text] [Related]
12. The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types.
Prins J; De Vries EG; Mulder NH
Anticancer Res; 1993; 13(5A):1373-85. PubMed ID: 8239508
[TBL] [Abstract][Full Text] [Related]
13. Retroviral v-myc infection of primary fetal liver cells: transformation of monocytes in vitro.
Birchenall-Roberts MC; Engelmann GL; Keller JR; Lohrey N; Ruscetti FW
Oncogene; 1989 Jun; 4(6):731-5. PubMed ID: 2786619
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of the structure and function of the chicken c-myc and v-myc genes: v-myc is a more potent inducer of cell proliferation and apoptosis than c-myc.
Petropoulos CJ; Givol I; Hughes SH
Oncogene; 1996 Jun; 12(12):2611-21. PubMed ID: 8700520
[TBL] [Abstract][Full Text] [Related]
15. The transcription activation domains of v-Myc and VP16 interact with common factors required for cellular transformation and proliferation.
Min S; Crider-Miller SJ; Taparowsky EJ
Cell Growth Differ; 1994 Jun; 5(6):563-73. PubMed ID: 8086335
[TBL] [Abstract][Full Text] [Related]
16. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
[TBL] [Abstract][Full Text] [Related]
17. [Effects of antisense N-myc gene on nerve growth factor-induced differentiation of neuroblastoma cell line].
Chen J; Liu T; Zhe X; Jiang J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Jun; 21(3):197-202. PubMed ID: 12569653
[TBL] [Abstract][Full Text] [Related]
18. Transforming ability of Gag-Myc fusion proteins correlates with Gag-Myc protein stability and transcriptional repression.
Law W; Linial ML
Oncogene; 2001 Mar; 20(9):1118-27. PubMed ID: 11314049
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
[TBL] [Abstract][Full Text] [Related]
20. The role of Ets family transcription factor PU.1 in hematopoietic cell differentiation, proliferation and apoptosis.
Oikawa T; Yamada T; Kihara-Negishi F; Yamamoto H; Kondoh N; Hitomi Y; Hashimoto Y
Cell Death Differ; 1999 Jul; 6(7):599-608. PubMed ID: 10453070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]